Form 8-K - Current report:
SEC Accession No. 0001437749-22-006370
Filing Date
2022-03-16
Accepted
2022-03-16 08:32:58
Documents
15
Period of Report
2022-03-16
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K kmph20220315_8k.htm   iXBRL 8-K 32663
2 EXHIBIT 99.1 ex_347546.htm EX-99.1 12378
7 kplogo.jpg GRAPHIC 13939
  Complete submission text file 0001437749-22-006370.txt   201235

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA kmph-20220316.xsd EX-101.SCH 3601
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kmph-20220316_def.xml EX-101.DEF 11532
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE kmph-20220316_lab.xml EX-101.LAB 15414
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kmph-20220316_pre.xml EX-101.PRE 11688
9 EXTRACTED XBRL INSTANCE DOCUMENT kmph20220315_8k_htm.xml XML 2564
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
KEMPHARM, INC (Filer) CIK: 0001434647 (see all company filings)

EIN.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36913 | Film No.: 22743394
SIC: 2834 Pharmaceutical Preparations